Companies · Instruments & Devices · 🇺🇸

Intuitive Surgical

ISRG · NYSE/NASDAQ · Instruments & Devices · $392 a share (close of 02 Oct 2026)

Available company data, source links and archived checks for Intuitive Surgical. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.

Net profit was $818.10 million.

Quarter ended 2026-06-30 · · Vendor / earlier record

Recorded quarterly figures
QuarterRevenue / incomeYoY ProfitYoYNet marginSource
Jun 2026Revenue: $2.9 bn—Net profit: $818 mn——Vendor / earlier record source
Mar 2026Revenue: $2.8 bn—Net profit: $822 mn——Vendor / earlier record source
Dec 2025Revenue: $2.9 bn—Net profit: $795 mn——Vendor / earlier record source
Sep 2025Revenue: $2.5 bn—Net profit: $704 mn——Vendor / earlier record source
Jun 2025Revenue: $2.4 bn—Net profit: $658 mn——Vendor / earlier record source
Mar 2025Revenue: $2.3 bn—Net profit: $698 mn——Source details incomplete

YoY means change from the same quarter a year earlier. — means no comparable figure is available. Older entries with incomplete source details have not been revalidated under the current checks.

The ownership tape — last 90 days, from disclosures
▼ Widman Fredrik (VP Corporate Controller) sold shares worth $204k · 15 Sep · SEC Form 4
▼ Widman Fredrik (VP Corporate Controller) sold shares worth $203k · 15 Sep · SEC Form 4
▼ Brosius Mark (EVP & Chief Mfg and Supply Cha) sold shares worth $29k · 21 Aug · SEC Form 4
▼ Brosius Mark (EVP & Chief Mfg and Supply Cha) sold shares worth $31k · 20 Aug · SEC Form 4
▼ Brosius Mark (EVP & Chief Mfg and Supply Cha) sold shares worth $30k · 19 Aug · SEC Form 4
▼ Brosius Mark (EVP & Chief Mfg and Supply Cha) sold shares worth $30k · 18 Aug · SEC Form 4
▼ Brosius Mark (EVP & Chief Mfg and Supply Cha) sold shares worth $30k · 17 Aug · SEC Form 4
Who holds it — from the filings
Invesco Ltd.BlackRock, Inc.VANGUARD CAPITAL MANAGEMENT LLCSTATE STREET CORPGEODE CAPITAL MANAGEMENT, LLCregister as filed 2026-08-31

Follow this company without reading every document yourself.

Keep its available filings, dated fact checks and disclosure alerts together. Your saved country sets your market and its research schedule.

Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment advice · cancel any time
Or just the free morning: three facts checked against filings, every trading day, in your inbox.

Company data and archived claim checks are shown with available sources. Check the source and date before relying on a figure. This is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI. Terms, disclosures and grievances